“Long-term Outcomes of Fixed-Combination Halobetasol Propionate and Tazarotene Lotion Stratified by Baseline Signs and Symptoms of Psoriasis” (2021) SKIN The Journal of Cutaneous Medicine, 5(6), p. s49. doi:10.25251/skin.5.supp.49.